◇ Our Standards
The lab.
How we verify.
Every compound we supply is manufactured to the highest research grade and independently verified before dispatch. We operate on a simple principle: if we wouldn't use it in our own research, we don't sell it.
01 — Synthesis
GMP-Compliant Manufacture
All compounds are synthesised under Good Manufacturing Practice conditions in ISO-certified facilities. Each batch is produced to a defined specification with full documentation.
02 — Analysis
HPLC Verification
High-performance liquid chromatography is run on every batch before release. We set a minimum threshold of 98.5% purity — most compounds exceed 99%. Results are on file and available on request.
03 — Mass Spec
Identity Confirmation
Mass spectrometry confirms molecular identity against the reference standard. This rules out analogues, impurities, and substitutions before any compound reaches our inventory.
04 — Sterility
Lyophilised Format
Compounds are freeze-dried under aseptic conditions and sealed in crimp-top glass vials. Lyophilisation ensures maximum stability and shelf life for in vitro research applications.
05 — Storage
Cold-Chain Integrity
Our UK warehouse operates at controlled 2–8°C ambient with −20°C deep-freeze capacity. All compounds are stored under appropriate conditions from receipt through dispatch.
06 — Certificates
COA on Every Order
A certificate of analysis is issued with every order, tied to the specific batch. It documents compound name, lot number, purity result, method, and date of analysis.
99%+
Minimum purity threshold
26
Active compounds in catalog
100%
Batches HPLC verified
COA
Issued with every order
◇ Reference Library
Clinical trials.
The research record.
A curated index of peer-reviewed studies and registered trials relevant to compounds in our catalog. Listed for reference only — not an endorsement of any therapeutic application. All compounds are sold for in vitro research use only.
| Compound |
Study Focus |
Institution / Registry |
Year |
Status |
| BPC-157 | Gastrointestinal cytoprotection and wound healing mechanisms in animal models | University of Zagreb | 2022 | Active |
| TB-500 | Actin sequestration and cellular migration in myocardial recovery models | NIH / PubMed PMID 34521892 | 2021 | Published |
| Epithalon | Telomerase activation and circadian rhythm modulation in ageing models | St. Petersburg Institute of Bioregulation | 2023 | Active |
| NAD+ | SIRT1-mediated DNA repair and mitochondrial biogenesis pathways | Harvard Medical School | 2023 | Active |
| GHK-Cu | Collagen I/III upregulation and dermal matrix remodelling in vitro | ClinicalTrials.gov NCT04821492 | 2022 | Published |
| Thymosin Alpha-1 | T-cell subset differentiation and innate immune activation in oncology models | National Cancer Institute | 2023 | Recruiting |
| Tirzepatide | Dual GIP/GLP-1 receptor agonism in metabolic syndrome research | Eli Lilly / SURMOUNT-1 Trial | 2022 | Published |
| Retatrutide | Triple receptor agonism for metabolic and adipose regulation | Eli Lilly / Phase 2 NCT04881760 | 2023 | Active |
| Selank | GABAergic modulation and anxiolytic mechanisms in CNS models | Institute of Molecular Genetics, Moscow | 2021 | Published |
| MOTS-c | AMPK pathway activation and metabolic homeostasis | USC Leonard Davis School | 2023 | Recruiting |
| Semax | BDNF and NGF transcription in neuroprotective research models | Russian Academy of Sciences | 2022 | Published |
| SS-31 | Cardiolipin interaction and mitochondrial membrane potential | University of Washington | 2023 | Active |
